Bal Pharma Announces 39th AGM on Sep 24, 2026; Sets Record Date for Dividend
Bal Pharma Limited will hold its 39th AGM on September 24, 2026, via VC/OAVM. The Record Date for the FY25-26 final dividend is September 17, 2026. E-voting will be open from September 21 to September 23, 2026.
This is a standard procedural announcement for an AGM and dividend, which is expected corporate activity and does not indicate any significant change in the company's operations or financial health.
The announcement is a routine corporate event related to the Annual General Meeting and dividend declaration, with no significant positive or negative financial implications mentioned.
Bal Pharma Limited has announced the details for its 39th Annual General Meeting (AGM), which is scheduled to be held on Thursday, September 24, 2026, at 11:30 A.M. (IST). The meeting will be conducted through Video Conferencing / Other Audio-Visual Means (VC/OAVM) in compliance with the Companies Act, 2013.
The company has fixed Thursday, September 17, 2026, as the Record Date for determining the eligibility of shareholders to receive the Final Dividend for the financial year 2025-26. This dividend recommendation is subject to the approval of the Members at the upcoming AGM.
Furthermore, Thursday, September 17, 2026, has also been designated as the Cut-off Date for electronic voting on the resolutions to be presented at the 39th AGM. The e-voting period will commence on Monday, September 21, 2026, at 9:00 A.M. and conclude on Wednesday, September 23, 2026, at 5:00 P.M. The Book Closure period is set from Friday, September 18, 2026, to Thursday, September 24, 2026, inclusive.
What to do with a filing like this
Bal Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bal Pharma Limited. Read the original for the full detail.